文献速递神经肌肉病

散发性肌萎缩侧索硬化的遗传风险再评估

The evolving genetic risk for sporadic ALS.
PubMed 文献 · Neurology · 2017-06-22

该研究对87例欧洲裔散发性肌萎缩侧索硬化(SALS)患者进行全外显子测序及C9orf72和ATXN2重复扩增检测,结合变异频率与MetaSVM预测的致病性评估31个ALS相关基因的遗传负荷。结果发现17.2%的SALS患者携带罕见有害变异或重复扩增,遗传负荷显著高于324名正常对照,但所贡献的遗传风险远低于既往估计。

要点

  • 结合变异频率与致病性预测可更准确评估SALS遗传风险。
  • 17.2%的SALS患者携带罕见有害变异或重复扩增。
  • SALS相关基因的遗传风险低于既往基于罕见性的估计。

核心结论

  • 结合变异致病性预测与频率分析,SALS相关基因贡献的遗传风险显著低于既往估计。

研究设计与样本

  • 对87例欧洲裔SALS患者行全外显子测序及C9orf72和ATXN2重复扩增PCR。
  • 对31个ALS相关基因的蛋白编码变异进行罕见性和MetaSVM预测致病性注释。
  • 与324名正常对照比较ALS相关基因的遗传负荷,计算比值比。

主要发现

  • 检出5个有害C9orf72重复扩增和2个ATXN2重复扩增。
  • 17.2%的SALS患者携带罕见有害变异或重复扩增。
  • MetaSVM预测的ALS相关基因遗传负荷在SALS患者中显著高于正常对照。

临床怎么用

  • 对SALS患者进行遗传评估时,应结合变异频率与致病性预测,而非仅依据罕见性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the genetic risk conferred by known amyotrophic lateral sclerosis (ALS)-associated genes to the pathogenesis of sporadic ALS (SALS) using variant allele frequencies combined with predicted variant pathogenicity. METHODS: Whole exome sequencing and repeat expansion PCR of C9orf72 and ATXN2 were performed on 87 patients of European ancestry with SALS seen at the University of Utah. DNA variants that change the protein coding sequence of 31 ALS-associated genes were annotated to determine which were rare and deleterious as predicted by MetaSVM. The percentage of patients with SALS with a rare and deleterious variant or repeat expansion in an ALS-associated gene was calculated. An odds ratio analysis was performed comparing the burden of ALS-associated genes in patients with SALS vs 324 normal controls. RESULTS: Nineteen rare nonsynonymous variants in an ALS-associated gene, 2 of which were found in 2 different individuals, were identified in 21 patients with SALS. Further, 5 deleterious C9orf72 and 2 ATXN2 repeat expansions were identified. A total of 17.2% of patients with SALS had a rare and deleterious variant or repeat expansion in an ALS-associated gene. The genetic burden of ALS-associated genes in patients with SALS as predicted by MetaSVM was significantly higher than in normal controls. CONCLUSIONS: Previous analyses have identified SALS-predisposing variants only in terms of their rarity in normal control populations. By incorporating variant pathogenicity as well as variant frequency, we demonstrated that the genetic risk contributed by these genes for SALS is substantially lower than previous estimates.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Gibson SB, Downie JM, Tsetsou S, et al. The evolving genetic risk for sporadic ALS. Neurology. 2017. PMID: 28642336. doi:10.1212/WNL.0000000000004109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。